Elekta’s Executive Management consists of the President and CEO, the Chief Financial Officer, the Chief Operating Officer, the managers of four product areas and the three regions – a total of ten members. The President and CEO oversees the work of the Executive Management and the Executive Management makes jointly decisions after consulting with the team. Executive Management meetings are held one or two days each month. The meetings, with Elekta’s General Counsel acting as secretary, are often held in conjunction with visits to the Group’s various units.
Details regarding remuneration of the President and CEO and Executive Management are provided in Note 5 in the annual report 2011/12.
President and CEO
Employed since 1988
Holdings*: 600,000 B-shares, 150,000 B-convertibles
Chief Operating Officer
Employed since 1993
Holdings*: 80,812 B-shares, 20,203 B-convertibles
Executive Vice President, Region Asia Pacific
Employed since 1998
Holdings*: 528,000 B-shares
Executive Vice President, Elekta Neuroscience
Employed 1994–2000 and since 2007
Holdings*: 1,308 B-shares, 327 B-convertibles
Executive Vice President, Elekta Oncology
Employed 2000–2008 and since 2011
Holdings*: 4,200 B-shares
James P. Hoey
Executive Vice President, Region North America
Employed since 2005 (Founded IMPAC 1990)
Holdings*: 6,000 B-shares
Executive Vice President, Elekta Software
Employed since 2005 (Employed at IMPAC since 1992)
Employed since 2001
Holdings*: 140,052 B-shares, 35,013 B-convertibles
Executive Vice President, Elekta Brachytherapy
Employed since 2011 (Employeed at Nucletron since 2009)
Holdings*: 5,000 B-shares
Executive Vice President Region Europe, Africa, Latin America and Middle East
Employed since: 2008-2011 and since 2012
Holdings*: 53,332 B-shares
* Reflects own and related natural or legal holdings in the company according to the insider register held by the Swedish Financial Supervisory Authority per December 17, 2012.
|President and CEO|
|The President and CEO is appointed by the Board of Directors and shall oversee the operational management of Elekta in accordance with the guidelines and directions stated in law, the articles of association and the internal operating instructions. |
Operational management includes all measures that are not – considering the scope and nature of the Company’s operations – of an unusual nature, of major significance, or are explicitly defined as the responsibility of the Board of Directors.
Tomas Puusepp has served as President and CEO of Elekta since May 1, 2005. Born in 1955, he has a total of 30 years of experience in international medical technology. Following studies in engineering and physics and management training at IMD in Lausanne, Switzerland, Tomas Puusepp held various positions at the Research Institute for Atomic Physics, Scanditronix and Ericsson before being employed by Elekta in 1988. Since then, he has held various management positions within the Company, including head of Elekta’s neurosurgery operations, President of Elekta’s subsidiary in North America and global head of Elekta’s sales, marketing and service operations.
Tomas Puusepp has no significant assignments outside Elekta. He has no shareholdings or ownership interests in companies with significant business relations with Elekta. Tomas Puusepp’s share and option holding in Elekta is noted in the above table.